Chromenone-based GSK-3ß inhibitors as potential therapeutic targets for cardiovascular diseases: In silico study, molecular dynamics, and ADMET profiles
Glycogen synthase kinase-3 beta (GSK-3ß) regulates glycogen metabolism and many different cellulars, including apoptosis, signaling, and neural. It is a crucial therapeutic receptor in heart disease, type 2 diabetes, and Alzheimer’s. In this study, using computational methods, flavonoid compounds we...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English English |
| منشور في: |
Elsevier B.V.
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://eprints.ums.edu.my/id/eprint/35099/1/ABSTRACT.pdf https://eprints.ums.edu.my/id/eprint/35099/2/FULL%20TEXT.pdf https://eprints.ums.edu.my/id/eprint/35099/ https://www.sciencedirect.com/science/article/pii/S1878535222006049 https://doi.org/10.1016/j.arabjc.2022.104288 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|